Since joining ONL in 2021, Amanda has been responsible for developing an in-house capability for accounting and financial reporting, a key area for the company’s future growth and success. Amanda most recently was senior accountant with Millendo Therapeutics, a publicly-traded, early-stage biopharma company where she managed internal accounting and finance processes, in addition to leading special projects for the implementation of enterprise-wide financial administration systems. Amanda has a background in corporate accounting from the technology manufacturing sector in addition to her degree in Management Science from University of California, San Diego.